Detailed TOC of Global Peptide Therapeutics Market Report, History and Forecast 2026-2035, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Peptide Therapeutics
1.1 Peptide Therapeutics Market Overview
1.1.1 Peptide Therapeutics Product Scope
1.1.2 Peptide Therapeutics Market Status and Outlook
1.2 Global Peptide Therapeutics Market Size Overview by Region 2026 VS 2026 VS 2035
1.3 Global Peptide Therapeutics Market Size by Region (2026-2035)
1.4 Global Peptide Therapeutics Historic Market Size by Region (2026-2026)
1.5 Global Peptide Therapeutics Market Size Forecast by Region (2026-2035)
1.6 Key Regions, Peptide Therapeutics Market Size (2026-2035)
1.6.1 North America Peptide Therapeutics Market Size (2026-2035)
1.6.2 Europe Peptide Therapeutics Market Size (2026-2035)
1.6.3 Asia-Pacific Peptide Therapeutics Market Size (2026-2035)
1.6.4 Latin America Peptide Therapeutics Market Size (2026-2035)
1.6.5 Middle East & Africa Peptide Therapeutics Market Size (2026-2035)
2 Peptide Therapeutics Market Overview by Type
2.1 Global Peptide Therapeutics Market Size by Type: 2026 VS 2026 VS 2035
2.2 Global Peptide Therapeutics Historic Market Size by Type (2026-2026)
2.3 Global Peptide Therapeutics Forecasted Market Size by Type (2026-2035)
2.4 Injection
2.5 Oral
2.6 Other
3 Peptide Therapeutics Market Overview by Application
3.1 Global Peptide Therapeutics Market Size by Application: 2026 VS 2026 VS 2035
3.2 Global Peptide Therapeutics Historic Market Size by Application (2026-2026)
3.3 Global Peptide Therapeutics Forecasted Market Size by Application (2026-2035)
3.4 Cancer
3.5 Metabolic Disorders
3.6 Central Nervous System
3.7 Other
4 Peptide Therapeutics Competition Analysis by Players
4.1 Global Peptide Therapeutics Market Size by Players (2026-2026)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2026)
4.3 Date of Key Players Enter into Peptide Therapeutics Market
4.4 Global Top Players Peptide Therapeutics Headquarters and Area Served
4.5 Key Players Peptide Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Peptide Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Peptide Therapeutics Products, Services and Solutions
5.1.4 Sanofi Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.1.5 Sanofi Recent Developments
5.2 Teva
5.2.1 Teva Profile
5.2.2 Teva Main Business
5.2.3 Teva Peptide Therapeutics Products, Services and Solutions
5.2.4 Teva Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.2.5 Teva Recent Developments
5.3 Novo Nordisk
5.3.1 Novo Nordisk Profile
5.3.2 Novo Nordisk Main Business
5.3.3 Novo Nordisk Peptide Therapeutics Products, Services and Solutions
5.3.4 Novo Nordisk Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Peptide Therapeutics Products, Services and Solutions
5.4.4 Takeda Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.4.5 Takeda Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Profile
5.5.2 Eli Lilly Main Business
5.5.3 Eli Lilly Peptide Therapeutics Products, Services and Solutions
5.5.4 Eli Lilly Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.5.5 Eli Lilly Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Peptide Therapeutics Products, Services and Solutions
5.6.4 AstraZeneca Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.6.5 AstraZeneca Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Peptide Therapeutics Products, Services and Solutions
5.7.4 Novartis Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.7.5 Novartis Recent Developments
5.8 AbbVie
5.8.1 AbbVie Profile
5.8.2 AbbVie Main Business
5.8.3 AbbVie Peptide Therapeutics Products, Services and Solutions
5.8.4 AbbVie Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.8.5 AbbVie Recent Developments
5.9 Ipsen
5.9.1 Ipsen Profile
5.9.2 Ipsen Main Business
5.9.3 Ipsen Peptide Therapeutics Products, Services and Solutions
5.9.4 Ipsen Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.9.5 Ipsen Recent Developments
5.10 Ferring
5.10.1 Ferring Profile
5.10.2 Ferring Main Business
5.10.3 Ferring Peptide Therapeutics Products, Services and Solutions
5.10.4 Ferring Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.10.5 Ferring Recent Developments
5.11 Merck
5.11.1 Merck Profile
5.11.2 Merck Main Business
5.11.3 Merck Peptide Therapeutics Products, Services and Solutions
5.11.4 Merck Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.11.5 Merck Recent Developments
5.12 The Medicines
5.12.1 The Medicines Profile
5.12.2 The Medicines Main Business
5.12.3 The Medicines Peptide Therapeutics Products, Services and Solutions
5.12.4 The Medicines Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.12.5 The Medicines Recent Developments
5.13 J & J
5.13.1 J & J Profile
5.13.2 J & J Main Business
5.13.3 J & J Peptide Therapeutics Products, Services and Solutions
5.13.4 J & J Peptide Therapeutics Revenue (US$ Million) & (2026-2026)
5.13.5 J & J Recent Developments
6 North America
6.1 North America Peptide Therapeutics Market Size by Country (2026-2035)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Peptide Therapeutics Market Size by Country (2026-2035)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Peptide Therapeutics Market Size by Region (2026-2035)
8.2 China
8.3 Japan
8.4 South Korea
8.5 India
8.6 Australia
8.7 China Taiwan
8.8 Indonesia
9 Latin America
9.1 Latin America Peptide Therapeutics Market Size by Country (2026-2035)
9.2 Mexico
9.3 Brazil
9.4 Argentina
10 Middle East & Africa
10.1 Middle East & Africa Peptide Therapeutics Market Size by Country (2026-2035)
10.2 Turkey
10.3 Saudi Arabia
10.4 U.A.E
11 Peptide Therapeutics Market Dynamics
11.1 Peptide Therapeutics Industry Trends
11.2 Peptide Therapeutics Market Drivers
11.3 Peptide Therapeutics Market Challenges
11.4 Peptide Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
